trending Market Intelligence /marketintelligence/en/news-insights/trending/DvaQTw4kHUzqHclt9u7Otw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Blueprint Medicines closes $325.5M common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Blueprint Medicines closes $325.5M common stock offering

Blueprint Medicines Corp. closed its public offering of common stock and raised about $325.5 million in net proceeds.

The company sold 4,259,259 common shares at $81.00 per share, which included the underwriters' full exercise of their option to buy additional shares.

Goldman Sachs & Co. LLC, Morgan Stanley and Cowen acted as joint book-running managers, while Canaccord Genuity acted as co-manager for the offering.